Skip to main content

What the FDA labels say about taking them together

Darunavir and rifapentine

Darunavir's FDA label of August 29, 2025 names rifapentine in its drug interactions section; the rifapentine label PlainMeds reads does not name darunavir. The darunavir label: “Co-administration of PREZISTA/ritonavir with rifapentine is not recommended.”

Check it at the source: the darunavir FDA label on DailyMed (effective August 29, 2025, Janssen Products LP); the rifapentine FDA label on DailyMed (effective February 6, 2026, sanofi-aventis U.S. LLC).

What does the darunavir label say about rifapentine?

Darunavir label, drug interactions

Concomitant Drug Class Drug Name Examples: rifapentine; Effect on Concentration of Darunavir Or Concomitant Drug: ↓ darunavir; Clinical Comment: Co-administration of PREZISTA/ritonavir with rifapentine is not recommended.

Source: FDA drug label (PREZISTA), Janssen Products LP, effective August 29, 2025 (SPL set 814301f9-c990-46a5-b481-2879a521a16f), via openFDA; the full label on DailyMed

What does the rifapentine label say about darunavir?

Rifapentine's label (effective February 6, 2026) does not name darunavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Priftin), sanofi-aventis U.S. LLC, effective February 6, 2026 (SPL set 3a64fb70-b85e-43d9-8bcd-7e893f568ae1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Darunavir generic labelers
1Rifapentine generic labelers
DarunavirRifapentine
Labeled forHIVn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$1.16 per tablet 600 mg tablet$4.83 per tablet 150 mg tablet
Shortage nowNo current entryResolved

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?